Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient

V. V. Orlova, X. Cao, C. Freund, G. Sanchez-Duffhues, L. Hawinkels, S. Petrus-Reurer, F. E. van den Hil, F. Disch, R. J. Snijder, C. J. J. Westermann, J. J. Mager, P. ten Dijke, Ploos J. K. van Amstel, C. L. Mummery

Research output: Contribution to journalMeeting AbstractAcademic

1 Citation (Scopus)

Abstract

SESSION 12 MECHANISMS OF HHT
Original languageEnglish
Pages (from-to)129-129
JournalAngiogenesis
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient'. Together they form a unique fingerprint.

Cite this